Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Post-acute Sequelae of SARS-CoV-2 Infection clinical trials
2 of 3 indexed Post-acute Sequelae of SARS-CoV-2 Infection trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Post-acute Sequelae of SARS-CoV-2 Infection: 3 US clinical trials tracked, 2 recruiting.
Post-acute Sequelae of SARS-CoV-2 Infection is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Family Health Centers of San Diego, running 1 of these trials.
Enrollment posture brief
Registry condition post-acute-sequelae-of-sars-cov-2-infection
OPEN 2 | RECR 67% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Post-acute Sequelae of SARS-CoV-2 Infection lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Post-acute Sequelae of SARS-CoV-2 Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Post-acute Sequelae of SARS-CoV-2 Infection is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Predictors of Post-COVID-19 Clinical and Cognitive Consequences
VA Office of Research and Development
NCT06291870
Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity
University of Colorado, Denver
NCT05566483
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
Family Health Centers of San Diego
NCT05167227
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Post-acute Sequelae of SARS-CoV-2 Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Post-acute Sequelae of SARS-CoV-2 Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Post-acute Sequelae of SARS-CoV-2 Infection page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Post-acute Sequelae of SARS-CoV-2 Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Family Health Centers of San Diego sponsors the most Post-acute Sequelae of SARS-CoV-2 Infection trials on record, review their full trial history before evaluating a specific study. See Family Health Centers of San Diego's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Post-acute Sequelae of SARS-CoV-2 Infection condition card totals 3 registered trials; most-linked intervention Extension for Community Healthcare Outcomes; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.